Pilot Study of Dexmedetomidine Sublingual Film for the Ambulatory Treatment of Hyperadrenergic Autonomic Crisis in Patients With Familial Dysautonomia
Running, not enrolling · Phase 2
Conditions studied: Familial Dysautonomia
In brief
This is a pilot open-label study to evaluate the feasibility of conducting a clinical trial using sublingual dexmedetomidine sublingual film to treat hyperadrenergic autonomic crises in patients with Familial Dysautonomia at home. The primary aims are to examine the feasibility of performing a clinical trial using dexmedetomidine at home to terminate autonomic crisis, and refine the interventions and assessments used to evaluate autonomic crisis termination.
Key facts
- Study ID
- NCT06128356
- Run by
- NYU Langone Health
- People needed
- 5
- Starts
- 2024-06-01
- Expected to finish
- 2028-12-01
- Last updated by the study team
- 2026-03-04
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Genetically confirmed diagnosis of Familial Dysautonomia.
- Evidence of autonomic crisis, previous treatment with IV dexmedetomidine without significant side effects, and registered medical data within the year preceding the study in our database.
- One or more autonomic crises during the last year.
- Age above 18 years.
- The patient has a responsible caretaker to communicate with the medical providers.
- Provision of signed and dated informed consent form from the patient and responsible caregiver.
- Able to state willingness to comply with all study procedures and availability for the duration of the study
- For males and females of reproductive potential: use condoms for contraception if sexually active.
You may not qualify if…
- At the consideration of the principal investigator, the caregiver cannot fully understand the protocol or communicate during the crisis with the Center.
- The patient during the crisis, before taking the medication, has any of the following:
- a. Oxygen saturation less than 92% on room air or baseline need for oxygen, change from baseline oxygen dependency.
- b. Respiratory rate >20 breaths per minute.
- c. Supine blood pressure ≤ 90/60mmHg
- d. Febrile illness with temperature >100.3 F.
- e. Serological signs of infection (WBC count >10 g/dL, or CRP >10 mg/L or ESR>20, or above their steady historical baseline levels) in recent (less than one month) studies.
- The patient is a female and has a positive pregnancy test.
- MoCA score <25 points.
Where it is running
- NYU Langone Health — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.